-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Embecta Corp. (NASDAQ:EMBC) Short Interest Update
Embecta Corp. (NASDAQ:EMBC) Short Interest Update
Embecta Corp. (NASDAQ:EMBC – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 3,900,000 shares, a decrease of 5.8% from the December 15th total of 4,140,000 shares. Based on an average daily volume of 643,400 shares, the short-interest ratio is currently 6.1 days. Approximately 6.9% of the company's shares are short sold.
Wall Street Analyst Weigh In
Separately, Morgan Stanley cut shares of Embecta from an "equal weight" rating to an "underweight" rating and set a $28.00 target price on the stock. in a research report on Friday, January 6th.
Get Embecta alerts:Embecta Trading Down 3.3 %
Shares of EMBC stock opened at $23.70 on Wednesday. Embecta has a fifty-two week low of $22.30 and a fifty-two week high of $49.00. The stock has a 50 day moving average price of $28.89 and a two-hundred day moving average price of $29.54.
Embecta (NASDAQ:EMBC – Get Rating) last posted its quarterly earnings results on Tuesday, December 20th. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.06. The company had revenue of $274.60 million during the quarter, compared to analyst estimates of $263.88 million. Embecta had a net margin of 19.80% and a negative return on equity of 52.41%. On average, analysts predict that Embecta will post 1.9 earnings per share for the current year.Embecta Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 11th. Investors of record on Friday, December 30th were paid a $0.15 dividend. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.60 annualized dividend and a dividend yield of 2.53%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Embecta during the third quarter valued at approximately $258,676,000. Vanguard Group Inc. bought a new position in Embecta in the 3rd quarter worth $197,911,000. State Street Corp purchased a new stake in shares of Embecta in the 3rd quarter worth about $68,114,000. Yacktman Asset Management LP bought a new stake in shares of Embecta during the 3rd quarter valued at about $66,598,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Embecta during the third quarter valued at about $29,545,000. Institutional investors own 93.45% of the company's stock.
About Embecta
(Get Rating)
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Featured Articles
- Get a free copy of the StockNews.com research report on Embecta (EMBC)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab's First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.
恩贝塔公司(纳斯达克代码:EMBC-GET Rating)12月份空头股数的销售额大幅下降。截至12月30日,空头股数共有390万股,比12月15日的414万股减少了5.8%。以日均成交量64.34万股计算,目前短息比为6.1天。该公司约6.9%的股票被卖空。
华尔街分析师也加入进来
另外,摩根士丹利将Embecta的股票评级从持平下调至减持,并为该股设定了28美元的目标价。在1月6日星期五的一份研究报告中。
到达恩贝塔警报:Embecta股价下跌3.3%
周三,EMBC的股票开盘报23.70美元。Embecta的股价为52周低点22.30美元,52周高点为49.00美元。该股的50日移动均线价格为28.89美元,200日移动均线价格为29.54美元。
Embecta(纳斯达克代码:EMBC-GET Rating)最近一次公布季度收益报告是在12月20日(星期二)。该公司公布本季度每股收益为0.73美元,比分析师普遍预期的0.67美元高出0.06美元。该公司本季度营收为2.746亿美元,而分析师预期为2.6388亿美元。Embecta的净利润率为19.80%,股本回报率为负52.41%。分析师平均预测,Embecta本年度每股收益将达到1.9欧元。恩贝塔股息公告
该公司最近还宣布了季度股息,股息于1月11日星期三支付。记录在案的投资者在12月30日(星期五)获得了0.15美元的股息。本次股息除息日期为12月29日星期四。这意味着年化股息为0.60美元,股息收益率为2.53%。
机构资金流入和流出
一些对冲基金和其他机构投资者最近买卖了该公司的股票。贝莱德股份有限公司在第三季度购买了新的Embecta股票头寸,价值约为258,676,000美元。先锋集团(Vanguard Group Inc.)在第三季度购买了Embecta的一个新头寸,价值197,911,000美元。道富银行在第三季度购买了Embecta的新股份,价值约68,114,000美元。Yacktman Asset Management LP在第三季度购买了Embecta的新股,价值约66,598,000美元。最后,纽约梅隆银行(Bank Of New York Mellon Corp)在第三季度购买了Embecta的新头寸,价值约29,545,000美元。机构投资者持有该公司93.45%的股票。
关于恩贝塔
(获取评级)
Embecta Corp.是一家医疗设备公司,专注于提供各种解决方案,以增进糖尿病患者的健康和福祉。它的产品包括笔针、注射器和安全设备,以及帮助人们管理糖尿病的数字应用程序。该公司主要向美国和国际上的批发商和分销商销售产品。
专题文章
- 免费获取StockNews.com关于Embecta的研究报告(EMBC)
- 柔顺治疗公司的差距增加了34%:未来还会有更多的好处吗?
- 2023年初裁员将如何影响这5只生物科技股?
- Baudax Bio投资者在经历了70%的飙升后,痛苦是否已经结束?
- 火箭实验室的首次美国发射将把斯托克送入平流层吗?
- Crane Holdings什么时候起飞?
接受《Embecta Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Embecta和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧